Phase 2 Trial Of CP-751,871 And Docetaxel In Advanced Breast Cancer

NCT00678626 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: CP-751,871
DRUG: Docetaxel

Sponsor

Pfizer